Grail Will Begin Selling Its Multi-Cancer Blood Test. It Could Be the Start of a Huge Market. June 4, 2021
GRAIL Presents Interventional PATHFINDER Study Data and Introduces Galleri, a Groundbreaking Multi-Cancer Early Detection Blood Test June 4, 2021
Pulmocide Raises $92 Million in a Series C Financing to Fund Registration Program for PC945 May 27, 2021
J&J-Backed Pulmocide Fills its Lungs with $92M Series C to Fund Phase 3, Ahead of Possible IPO May 27, 2021
